Objective: To investigate the liver cellular apoptosis in response to burn injury and find out if statin treatment can ameliorate this process. The hypothesis is that statin may modulate apoptosis-related gene expression and thereby reduce hepatocytic apoptosis after burn injury. Methods: Mice were subjected to 30% full-thickness burn injury and then treated either with or without simvastatin. The livers were harvested for histological assessment and determinations of gene expression. To investigate the mechanism involved, tumor necrosis factor (TNF)-α and caspase-3 knockout (KO) mice were also used to evaluate the effects of burn injury and simvastatin treatment on burn-induced liver injury. The effects of simvastatin on TNF-α and caspase-3 expressions were also evaluated in cultured mouse hepatocytes. Results: Burn injury induced significant liver damage, which was indicated by striking levels of apoptosis. Simvastatin reduced the apoptotic index in the livers of mice with burn injury and this effect could be abrogated by TNF-α or caspase-3 inhibitors. Simvastatin also decreased burn-induced TNF-α and caspase-3 expression in the liver. TNF-α and caspase-3 KO mice demonstrated lower levels of apoptotic hepatocytes in response to burn, and simvastatin did not further decrease hepatocyte apoptosis in either strain of KO mice. An in vitro study demonstrated that simvastatin suppresses TNF-α and caspase-3 expression in primary cultures of mouse hepatocytes. Conclusions: Simvastatin reduces mouse hepatocyte apoptosis by suppressing expression of the TNF-α/caspase-3 pathway.
glutaryl coenzyme-A reductase activity. 6, 7 Simvastatin interferes with the synthesis of farnesyl pyrophosphate. Farnesyl pyrophosphate is needed for many biosynthetic pathways, including the synthesis of ubiquinone, a component of the mitochondrial respiratory chain, and post-translational lipidation of proteins. These pathways are all involved in cellular apoptosis. 8 However, the underlying mechanisms remain obscure.
The primary use of statins is to treat hypercholesterolemia 6 ; however, accumulating data suggest that statins also exert antiinflammatory effects by decreasing the formation of proinflammatory cytokines, chemokines, and reactive oxygen species. 9, 10 Burn injury can induce significant inflammatory reactions in the liver, which may trigger or promote hepatic cellular apoptosis. However, it is not known whether statins suppress susceptibility to burn-induced hepatic apoptosis via their anti-inflammatory properties. Clinically, statins have been shown to decrease the morbidity and mortality rate in burn patients, which is attributable to reduction of liver complications. 11 Therefore, we hypothesize that the protective role of statins on the liver is related to a reduction of apoptosis and it is necessary to evaluate the effects of statins on hepatocyte apoptosis.
Tumor necrosis factor (TNF)-α, a key mediator of the effects of burn injury, has been shown to promote leukocyte recruitment and to induce hepatocyte apoptosis in some disease conditions. 8, 12 TNF-α initiates cellular apoptosis as a potent extracellular stimulator. Downstream of the apoptotic TNF-α signaling pathway, caspase-3 plays a crucial role in the guidance of cells to undergo apoptosis. 13 Cleavage of pro-caspase-3 leads to active caspase-3 expression. Furthermore, Slotta and colleagues 14, 15 have found that simvastatin can reduce TNF-α expression and apoptosis in endotoxin-induced liver injury. It is not clear whether burn injury promotes TNF-α expression in the liver or if simvastatin affects hepatocellular apoptosis via the TNF-α/caspase-3 pathway.
In this study, we hypothesized that treatment with simvastatin reduces burn-induced apoptosis and may exert this anti-apoptotic activity by reducing proinflammatory cytokines, specifically, TNF-α and caspase-3. To test this hypothesis, we used an experimental model in which mice were exposed to thermal injury and then treated with simvastatin.
was obtained from Sigma Aldrich (St. Louis, MO). Dulbecco Modified Eagle Medium, fetal calf serum, and penicillin/streptomycin were obtained from GIBCO (New York, NY).
Animals
Wild type C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME) were divided into 3 groups: sham burn, burn with saline treatment, and burn injury with simvastatin treatment. The extent of hepatic apoptosis was evaluated in these animals. For further evaluation of the protective effect of simvastatin in relation to inflammatory status, animals were treated with TNF-α inhibitor (Pentoxifylline) and caspase-3 inhibitor (Ac-DEVD-CHO). The effects of simvastatin were also measured in a hepatic cell culture system. Finally, studies were also conducted on TNF-α −/− and caspase-3 −/− (C57BL/6 genetic background, Jackson Laboratory) animals, to further explore the effects of simvastatin and inflammation mediators on apoptosis. The study was approved by the Subcommittee on Research Animal Care of the Massachusetts General Hospital, Harvard University, and is in compliance with the Guide for the Care and Use of Laboratory Animals (Publication No. NIH 78- 23, 1996) .
Burn Injury Model
Male mice weighing 20 to 25 g were used in this study. As previously described in reports from Shriners Hospital for Children laboratory, 16 all animals received general anesthesia (ketamine 40 mg/kg body weight and xylazine 5 mg/kg body weight, intraperitoneally) before burn injury. A full-thickness thermal injury of 30% of the total body surface area was produced by shaving the dorsal surface of the animals with animal hair clippers. The animals were then placed in molds exposing 30% of the dorsum followed by exposure of the open area to a 90 • C water bath for 9 seconds. The mice were immediately resuscitated with a 1.5 mL saline intraperitoneal injection. Sham control mice were treated similarly; however, the water bath was set to room temperature. After the procedure, the mice were caged individually.
Immediately after burn injury, the simvastatin-treated mice were injected with 100 μg/kg of simvastatin intraperitoneally and a second dose was administered 12 hours later. The inhibitor-treated mice were administered 50 μg/kg of TNF-α inhibitor (Pentoxifylline) or 50 μg/kg of caspase-3 inhibitor (Ac-DEVD-CHO) intraperitoneally immediately after injury and a second dose was administered 12 hours later on the day of the procedure. In the control group, sham-treated mice received the same volumes of saline.
Histopathological Examination
The mouse liver specimens were fixed in 10% formaldehyde and embedded in paraffin. Tissue sections (5 μm) were stained with hematoxylin and eosin and then examined with light microscopy by experienced pathologists, unaware of the treatment conditions, to detect the histopathological changes (5 mice in each group).
Evaluation of Hepatocyte Apoptosis
Liver sections (4 μm) were deparaffinized in xylene and dehydrated in graded ethanol. Apoptotic cells were identified using terminal deoxynucleotidyl transferase dUTP nick-end labeling kit. Ten random fields from 3 slides per group were examined and the terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive brown nuclei within the hepatocytes were scored as previously described. 17 The data were expressed as the percentage of terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive cells out of100 hepatocytes. Digitized images were analyzed by 2 blinded investigators. In the time course study of hepatocyte apoptosis, the liver specimens were collected 6, 12, 24, 72, and 144 hours (5 mice in each time point) after thermal injury, and terminal deoxynucleotidyl transferase dUTP nick-end labeling staining was used for evaluation of apoptosis.
Western Blot Analysis and Time Course Study on TNF-α and Caspase-3 Expression in the Liver
Total hepatic protein was extracted and concentration was measured by the Bradford method. Equal amounts of protein from each sample were loaded onto 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred onto equilibrated polyvinylidene difluoride membranes by electroblotting. The membranes were incubated overnight at 4 • C with primary antibodies. After incubation with the secondary antibody, proteins were detected by an enhanced chemiluminescence kit (Amersham Corporation). The level of expression of each protein was normalized to the expression level of glyceraldehyde 3-phosphate dehydrogenase (a house keeping gene) in the same sample. Bands were quantified by scanning densitometry using the digital Kodak Gel Logic 200 system (Carestream Molecular Imaging).
In the time course study of gene expression, liver specimens were collected 6, 12, 24, and 72 hours after the thermal injury. Sham group: n = 4, other groups: n = 6 (the experiment was repeated once). Liver proteins were isolated and Western blot analysis of TNF-α and caspase-3 expression was performed.
Primary Culture of Hepatocytes and Treatment
Mouse hepatocytes were isolated by a collagenase perfusion technique according to previous methods with minor modifications. 18 The livers were perfused in situ via the portal vein with 75 mL of Krebs Ringer Buffer, followed by 100 mL of Krebs Ringer Buffer containing collagenase at a concentration of 150 units/mL. The flow rate was 10 mL/min. Digested liver was then removed and shaken in Petri dishes with sterile forceps to release the cells into Krebs Ringer Buffer. Isolated cells were collected with a 60-μm cell filter and low-speed centrifugation (450 rpm). Viable hepatocytes were further purified by the isodensity Percoll centrifugation method and plated onto 60-mm plastic dishes at a density of 3 × 10 5 hepatocytes per dish. The basal culture medium was Dulbecco Modified Eagle Medium supplemented with 10% fetal calf serum and penicillin/streptomycin. Viability of the hepatocytes was evaluated by the trypan blue exclusion test and the culture medium was renewed 4 hours after initial plating. From the second day on, simvastatin was added at a concentration of 20 μg/mL of medium. The medium was changed once per day for 3 days. Protein was then isolated from the cultured cells for analysis.
Statistical Analysis
Data are presented as mean values ± standard error of the mean. Statistical evaluations were performed using an analysis of variance and Student t tests wherever indicated. P values less than 0.05 were considered significant and n represents the number of animals per group. liver sectionsdemonstrated occasional apoptosis in the sham-treated mice (Fig. 1C) . In contrast, a remarkable increase in the number of terminal deoxynucleotidyl transferase dUTP nick-end labeling-positive hepatocytes indicated widespread hepatocyte apoptosis in the livers of mice with burn injury (Fig. 1D ). The apoptotic cells were present in a diffuse distribution pattern. Figure 2 illustrates the time course of apoptosis in the livers from mice with burn injury and sham-treated controls. Apoptosis was detected within 6 hours after the burn increased over time, peaked 24 hours after burn injury, and decreased gradually thereafter. The striking apoptosis was apparent throughout the entire course of the 6-day study in thermally injured mice. Two-way analysis of variance demonstrated significant main effects of treatment (burn vs sham): F 1, 50 = 647.27, P < 0.0001; time after injury: F 4, 41 = 96.44, P < 0.001; and treatment by time interaction: F 4, 41 = 80.77, P < 0.0001. In sham-treated animals, there was no evidence of increased apoptosis over the 6-day observation period. Twelve hours, 1 day, 3 days, and 6 days after injury, there was an increase in apoptosis in the livers of burn-injury mice compared with sham-treated animals (P < 0.05, P < 0.001, P < 0.01, and P < 0.05, respectively. One, 3, and 6 days after injury, apoptosis was increased compared with 12 hours after injury (P < 0.001, P < 0.01, and P < 0.05, respectively). Compared with 1 day after injury, apoptosis decreased 3 and 6 days after injury (P < 0.05). These findings indicate that a full-thickness burn in mice produces remote hepatic injury that is manifested as significant hepatocellular apoptosis. Figure 3 illustrates the levels of TNF-α and caspase-3 expression in the livers from mice with burn injury and sham-treated controls. In the sham-treated animals, expressions of TNF-α and caspase-3 were mildly detectable in the liver; however, when the mice were exposed to thermal injury, both TNF-α and caspase-3 expressions were remarkably increased. The time course data demonstrated that both TNF-α and caspase-3 expression gradually increased after burn injury, peaking 12 to 24 hours after burn, and gradually decreasing 3 days after burn.
RESULTS

Burn-Induced Liver Damage and Cellular Apoptosis
Effect of Burn Injury on TNF-α and Caspase-3 Expression in the Liver
Effect of Simvastatin on Burn-Induced Hepatic Cellular Apoptosis
The effect of simvastatin treatment on burn-induced hepatic cellular apoptosis is illustrated in Figure 4 . One-way analysis of variance demonstrated a highly significant effect of treatment F 3, 23 = 73.06, P < 0.0001. In contrast with the untreated and saline-treated mice, simvastatin reduced the apoptosis index significantly (P < 0.001) 24 hours after the burn injury, indicating a strong anti-apoptotic property of simvastatin in peripheral burn-induced liver injury. Figure 5 illustrates the effect of simvastatin on TNF-α and caspase-3 expression. Compared with saline-treated mice, simvastatin-treated mice showed a large reduction in TNF-α and caspase-3 expression in the liver. Simvastatin treatment decreased burn-induced hepatic cellular apoptosis, and reduced TNF-α and caspase-3 expression. These findings indicate that simvastatin can reduce hepatocyte apoptosis by suppressing the TNF-α/caspase-3 signaling pathway (Figs. 5A, B) .
Effect of Simvastatin on Burn-Induced TNF-α and Caspase-3 Expression in Livers and Cultured Mouse Hepatocytes
The effects of simvastatin were further substantiated by an in vitro study in which cultured mouse hepatocytes were treated with simvastatin for 3 days. The results showed that simvastatin decreased both TNF-α and caspase-3 expression in the cultured cells Figure 6 illustrates the effect of TNF-α and caspase-3 inhibitors on hepatic apoptosis in mice with burn injury. One-way analysis of variance on the TNF-α data in Figure 6A demonstrated a highly significant effect of treatment: F 4, 28 = 60.37, P < 0.001. As expected, burn produced a significant increase in apoptosis (P < 0.001). This effect was partially reversed by treatment with TNF-α inhibitor, inhibitor plus statin (P < 0.01). One-way analysis of variance of the caspase-3 data in Figure 6B demonstrated a highly significant effect of treatment: F 4, 28 = 42.65, P < 0.001. As expected, burn produced a significant increase in apoptosis (P < 0.001). This effect was partially reversed by treatment with caspase-3 inhibitor, inhibitor plus statin (P < 0.01). Overall, these results indicate that in animals with burn injury, the treatment effects of simvastatin on hepatocytic apoptosis were partially blocked by Pentoxifylline and Ac-DEVD-CHO, suggesting a potential pathway by which simvastatin exerts its antiapoptotic activity. Figure 7 illustrates the effects of TNF-α and caspase-3 knockout (KO) on burn-induced liver apoptosis. One-way analysis of variance on TNF-α KO's data demonstrated a highly significant effect of treatment: F 4, 28 = 67.93, P < 0.0001. As expected, burn produced a significant increase in apoptosis (P < 0.001). This effect was significantly (P < 0.01) reduced by all of the treatments. One-way analysis of variance on caspase-3 KO's data demonstrated a highly significant effect of treatment: F 4, 24 = 42.99, P < 0.0001. As expected, burn produced a significant increase in apoptosis (P < 0.005). This effect was significantly (P < 0.01) reduced by all of the treatments. Overall, these results indicate that compared with wild-type mice, TNF-α −/− and caspase-3 −/− mice demonstrated significantly lower levels of apoptosis in the liver after burn injury. Levels of hepatic apoptosis in KO mice treated with simvastatin were not significantly different from levels of these mice without statin treatment. These findings further indicated that simvastatin reduces apoptosis in burn-injured mice, at least partially, via the TNF-α/caspase-3 pathway.
Effects of TNF-α, Caspase-3 Inhibitors, and Simvastatin in Burn Injury-Induced Hepatic Apoptosis
Hepatic Apoptosis in TNF-α −/− and Caspase-3 −/− Mice
DISCUSSION
Statins, 3-hydroxy 3-methyl-glutaryl coenzyme-A reductase inhibitors, are cholesterol-lowering agents that are widely used in the treatment and prevention of atherosclerosis. 19, 20 This study investigated the effects of simvastatin on hepatocellular apoptosis in response to burn injury in mice, and further evaluated the underlying mechanism through which simvastatin protects the liver.
Burn Injury-Induced Apoptosis in Mouse Liver
The results of this study indicated that severe burn injury leads to a broad area of cellular destruction in the mouse liver. Furthermore, terminal deoxynucleotidyl transferase dUTP nick-end labeling staining demonstrated remarkable hepatic apoptosis in the livers of burn-injured mice throughout the study period. These results confirmed that damage to the liver is a direct effect of burn injury and mainly presents as hepatocellular apoptosis. These findings are consistent with previous clinical investigations, which have demonstrated that severe burn injury can induce significant hepatic dysfunction. 21 The thermal-injury animal model used in this study accurately represents the phenomena observed in burn patients. Previous studies have also suggested that remote liver injury may be induced by tissue oxidative stress provoked by burn injury and that this stress is closely related to several inflammation-related processes during which many cytokines and chemokines play important roles. 22
Inflammation and Hepatic Apoptosis
The role of TNF-α in apoptosis has been well established. TNF-α acts as an extrinsic stimulator that triggers cellular apoptosis. TNF-α receptor-associated death domain and Fas-associated death domain proteins lead to activation of caspases, including caspase-3. 23 TNF-α-induced PI3K activation results in the generation of reactive oxygen species, which then activate caspase-3. The TNF-α/caspase-3 pathway operates in many types of cells, including hepatocytes. 24, 25 In this study, low levels of TNF-α and caspase-3 expression were detected in the livers of normal mice. However, when mice were exposed to thermal injury, expression of these proteins was significantly increased, indicating that thermal injury leads to activation of the TNF-α/caspase-3 signaling pathway, which is responsible for burn-induced liver injury. This argument is further supported by our findings that the use of TNF-α inhibitor and caspase-3 inhibitor (Fig. 6) , and depletion of TNF-α or caspase-3 genes in TNF-α −/− and caspase-3 −/− animals significantly ameliorated the burninduced hepatic apoptosis (Fig. 8 ). Therefore, these results suggest that the TNF-α/caspase-3 pathway is involved in burn injury-induced hepatocellular apoptosis.
Simvastatin and Hepatic Apoptosis After Thermal Injury, and the TNF-α /Caspase-3 Pathway
The results of this study demonstrated that treatment with simvastatin in animals with burn injury significantly reduced the liver apoptosis index (Fig. 4) . This was further supported by the in vitro studies that the addition of simvastatin into a hepatocyte culture medium reduced TNF-α and caspase-3 expression ( Fig. 4) indicating its potent anti-apoptotic properties in burn-induced liver injury.
Our studies further revealed the possible mechanism of this protective effect by simvastatin. First, the anti-apoptotic effect of simvastatin was accompanied by a significant reduction of hepatic expressions of TNF-α and caspase-3 in livers from animals with burn injury (Figs. 5A, B) . Second, TNF-α and caspas-3 inhibitors abrogated the burn injury-induced hepatic apoptosis (Fig. 6) . Third, addition of simvastatin to TNF-α and caspase-3 inhibitors did not show significant further reduction of apoptosis. Fourth, in TNF-α −/− and caspase-3 −/− animals, burn injury did not cause significant increase of hepatic apoptosis as compared with that in wild type animals ( Fig. 7) . Furthermore, in TNF-α −/− and caspase-3 −/− animals, administration of simvastatin to animals with burn injury did not cause significant reduction in apoptosis. All these findings suggested that the anti-apoptotic effect of simvastatin involves the mechanism of inhibiting the TNF-α/caspase-3 pathway.
The Protective Role of Simvastatin in Burn-Induced Liver Injury and Its Clinical Implication
Hepatic apoptosis has been recognized as part of the pathological changes after burn injury. 26, 27 High apoptotic cell numbers after burn injury implicate hepatic damage and impairment to liver function. Results from this study strongly suggested a protective role of simvastatin on hepatocyte apoptosis. Clinical reports have demonstrated that simvastatin decreased the morbidity and mortality of burn patients. 11 Our earlier studies using a burn-sepsis animal model also found that statin treatment reduced total mortality when it started 2 and 4 hours after the insult. 18 The reduction of mortality is at least partially attributable to that of liver damage. 11 The focus of this study was to explore burn injury-induced hepatic apoptosis, the protective role of simvastatin in reducing apoptosis, and the mechanisms involved in this role. The study was conducted in a 30% full-thickness burn model with low mortality. Therefore, this study did not use mortality as an end point.
CONCLUSIONS
This study demonstrated that peripheral thermal injury leads to remote hepatocyte apoptosis and that simvastatin treatment can significantly attenuate this process by decreasing activity of the TNF-α/caspase-3 signaling pathway. These novel findings provide a mechanistic platform for understanding how statin treatment reduces morbidity and mortality in burn patients and suggest that the TNF-α/caspase-3 pathway may represent a new target for the development of more effective treatment regimens to protect liver function after burn injury. Further studies will be necessary to completely FIGURE 6. Effects of TNF-α and caspase-3 inhibitors on hepatic apoptosis in mice with burn injury. A, Effects of the TNF-α inhibitor, Pentoxifylline (50 μg/kg, IP), on apoptosis. Each value is the mean ± standard error of the mean for n = 5 animals with each treatment ( * P < 0.01 vs all other groups; * * P < 0.01 vs sham, burn; * * P > 0.05: burn/inhibitor vs burn/inhibitor/statin). B, Effects of the caspase-3 inhibitor, Ac-DEVD-CHO (50 μg/kg, IP), on apoptosis. Each value is the mean ± standard error of the mean for n = 5 animals with each treatment. Burn injury induced marked hepatocellular apoptosis, which was partially reversed by treatment with simvastatin, TNF-α or caspase-3 inhibitors ( * P < 0.01 vs all other groups; * * P < 0.01 vs sham, burn; * * P > 0.05: burn/inhibitor vs burn/inhibitor/statin). IP indicates intraperitoneally.
FIGURE 7.
Effects of TNF-α and caspase-3 KO on burn-induced liver apoptosis. A, Effects of TNF-α KO on apoptosis in mouse liver. Each value is the mean ± standard error of the mean for n = 5 animals with each treatment (ANOVA: * P < 0.001; * * P > 0.05). B, Effects of caspase-3 KO on apoptosis in mouse liver (ANOVA: * P < 0.001; * * P > 0.05). Each value is the mean ± standard error of the mean for n = 5 animals with each treatment. Representative histological images of TUNEL-stained liver sections are also illustrated with examples of apoptotic cells indicated by arrows. Compared with the wild-type mice, TNF-α −/− and caspase-3 −/− mice demonstrated much lower levels of apoptosis in the liver after burn injury. The levels of apoptosis in the KO mice treated with simvastatin were not significantly different from levels in knockout mice without statin treatment, indicating that statins might reduce apoptosis in burn injured mice, at least partially, through inhibition of the TNF-α/ caspase-3 pathway. ANOVA indicates analysis of variance; KO, knockout; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.
understand the effects of liver apoptosis on overall survival after thermal injury and if the protective effects of simvastatin involve other signal transduction pathways of hepatic apoptosis.
